2026 대한내분비학회 추계학술대회 및 학연산 심포지엄 | 2026.10.19(목) ~ 31(토) | 창원컨벤션센터
프로그램
- Plenary lecture
- Presidential lecture
- Award lecture
- 연구회 심포지엄
- Joint symposium
- 학연산 심포지엄
- Breakfast / Luncheon symposium
- 갑상선
- 근육/미네랄/골대사
- 뇌하수체/부신/생식
- 당뇨병/비만/지질(기초)
- 당뇨병/비만/지질(임상)
- 위원회 세션
- 초음파 세션
Breakfast / Luncheon symposium
-
Breakfast symposium 1(한독/사노피)
10월 30일(금) 07:30-08:20, Room1
좌장: 오태근(충북의대), 진흥용(전북의대)
| 07:30-07:55 |
|
TERA Study: First Evidence of Teneligliptin Add-on to Metformin plus Empagliflozin in Korean Patients with Type 2 Diabetes
문준성(영남의대) |
| 07:55-08:20 |
|
Importance of Timely Insulin Initiation: Optimizing Glycemic Control with 2nd generation Basal Insulin Following GLP-1 RA Treatment 김규리(성균관의대) |
-
Breakfast symposium 2(바이엘코리아)
10월 30일(금) 07:30-08:20, Room2
좌장: 김동선(한양의대), 김숙경(건국의대)
| 07:30-07:55 |
|
The Pivotal Role of finerenone in Early Cardiorenal Protection
윤재승(가톨릭의대) |
| 07:55-08:20 |
|
Evolving Treatment Paradigm with finerenone: Addressing High Unmet Needs in CKD 배재현(서울의대) |
-
Breakfast symposium 3(사노피/유한양행)
10월 31일(토) 07:30-08:20, Room1
좌장: 김은숙(울산의대), 김혜순(계명의대)
| 07:30-07:55 |
|
Is better possible?: Simplifying and amplify diabetes management with FRC intensification
곽인선(연세의대) |
| 07:55-08:20 |
|
One Pill, Broader Benefits; Esgliteo in the Early T2D Journey 김수경(경상국립대) |
-
Breakfast symposium 4(셀트리온/JW중외제약)
10월 31일(토) 07:30-08:20, Room2
좌장: 박성우(고신의대), 박철영(성균관의대)
| 07:30-07:55 |
|
Pioglitazone: A Valuable Option in Diabetes Care
김부경(고신의대) |
| 07:55-08:20 |
|
Cutting Egde Care of Pitavastatin with Ezetimibe Combination Therapy 오태정(서울의대) |
-
Luncheon symposium 1(한국릴리/노보노디스크)
10월 30일(금), 11:50-12:40, Room1
좌장: 김광원(가천의대), 이형우(영남의대)
| 11:50-12:15 |
|
SURPASS-EARLY: Early Stage, Right Timing for Long-term Outcomes in T2D
이준엽(가톨릭의대) |
| 12:15-12:40 |
|
Optimizing Glycemic Control Through Once-Weekly Treatment Intensification: The Clinical Value of IcoSema 이민영(연세의대) |
-
Luncheon symposium 2(JW중외제약/한미약품)
10월 30일(금), 11:50-12:40, Room2
좌장: 성연아(이화의대), 한승진(아주의대)
| 11:50-12:15 |
|
Enhancing Glycemic Control in T2DM: The Strategic Integration of DPP-4i and SGLT-2i Therapy
이용호(연세의대) |
| 12:15-12:40 |
|
Efpeglenatide: A New Chapter in Obesity Management for Korean Patients 이은영(가톨릭의대) |
-
Luncheon symposium 3(대웅제약/종근당)
10월 31일(토), 11:50-12:40, Room1
좌장: 김철희(순천향의대), 박석오(박샘내과)
| 11:50-12:15 |
|
Advances in Diabetes Management: Clinical Benefits of SGLT-2 Inhibitors in Combination Therapy
김혜진(아주의대) |
| 12:15-12:40 |
|
The Proven and the New: Updating Sitagliptin’s Role in Type 2 Diabetes Management 김유지(경상의대) |
-
Luncheon symposium 4(LG화학/베링거인겔하임)
10월 31일(토), 11:50-12:40, Room2
좌장: 이관우(아주의대), 박형규(순천향의대)
| 11:50-12:15 |
|
Does Switching Within the DPP-4 Inhibitor Class Make a Real Difference? : Integrating Korean RWE into Diabetes Care
최훈성(중앙의대) |
| 12:15-12:40 |
|
Redefining early CKM Care in T2D treatment 김혜경(연세의대) |
